Search results
Regeneron Pharmaceuticals (NASDAQ:REGN) Upgraded to Strong-Buy by Evercore ISI
ETF DAILY NEWS· 21 hours agoEvercore ISI upgraded shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) to a strong-buy rating in a report released on Monday, Zacks.com reports ...
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) large institutional owners must be happy as stock...
Simply Wall St. via Yahoo Finance· 7 days agoKey Insights Institutions' substantial holdings in Regeneron Pharmaceuticals implies that they have...
These 2 No-Brainer Growth Stocks Are Breaking New Ground
Motley Fool via Yahoo Finance· 17 hours agoDrugmakers outside the biosimilar or generic-medicine market must constantly innovate to be...
Qsemble Capital Management LP Purchases Shares of 239 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 3 days agoQsemble Capital Management LP acquired a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the 4th quarter, according ...
Examining the Potential Price Growth of Regeneron Pharmaceuticals, Inc.
Knox Daily· 2 days agoRegeneron Pharmaceuticals, Inc.’s filing revealed that its EVP Commercial McCourt Marion unloaded Company’s shares for reported $0.22 million on May 01 ...
Warren Township Will Welcome Regeneron Pharmaceuticals
TAPinto.net· 2 days agoWarren Township Will Welcome Regeneron Pharmaceuticals
Regeneron, Sanofi Get Speedy FDA Review of Dupixent in Younger CRSwNP Group
Morningstar· 4 days agoRegeneron Pharmaceuticals and Sanofi have won Food and Drug Administration priority review of their application seeking expanded approval of their blockbuster ...
...s How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 10 Years - ...
Benzinga· 3 days agoRegeneron Pharmaceuticals REGN has outperformed the market over the past 10 years by 2.01% on an annualized basis producing an average annual return of ...
... for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) - ...
Benzinga· 4 days agoRegeneron Pharmaceuticals, Inc. REGN and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental ...
Keeping Muscle While Losing Fat Is Next Goal for Obesity Drugs
Bloomberg· 31 minutes agoThe new blockbuster weight-loss shots can help patients trim more pounds than any medicines have...